Long-term efficacy and safety of obeticholic acid in patients with PBC from the POISE trial grouped biochemically by risk of disease progression. (March 2021) - Bowlus, C.L.; Trauner, M.; Liberman, A.; Malecha, E.; MacConell, L.; Kremer, A.E.; Nevens, F.; Floreani, A.